USGet the app
Entertainment

IISc researchers combine antibiotics to tackle drug-resistant TB

Thehindu··Bengaluru
IISc researchers combine antibiotics to tackle drug-resistant TB

Bengaluru Researchers at the Indian Institute of Science (IISc), have identified a strategy to restore the effectiveness of isoniazid, a frontline drug used to treat tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis). According to the IISc, TB caused by M. tuberculosis, continues to remain one of the world’s most persistent health challenges. However, it said that what’s particularly alarming is the bacterium’s growing resistance to isoniazid. In combination Now, researchers at the Department of Biochemistry have now identified a strategy to restore the effectiveness of isoniazid – by combining it with another antibiotic, vancomycin. They found that this combination can reverse isoniazid resistance in clinical isolates of M. tuberculosis and reduce bacterial burden in a mouse model. “Isoniazid resistance poses a major challenge in the treatment of TB. To tackle this problem, we started exploring ways to rescue the drug by reversing resistance,” said Nagasuma Chandra, Professor at the Department of Biochemistry and corresponding author of the study published in Microbiology Spectrum. PhD student and first author of the study, Sukriti Pal said that although several antibiotic combinations are available for TB treatment challenges presist due to drug-resistance. Reversing resistance She said that the new study identifies a drug treatment strategy that can reverse resistance to isoniazid, an otherwise highly effective antibiotic. The…

Read more at thehindu.com
Ad
0Like0Dislike0Comments0Shares

Comments 0

No comments yet. Be the first to share your view in the app.

Join the discussion: comments and votes are in the free Beloud app.